Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function

Table 1 Patient and clinical characteristics of HCC group

Patient number	Gender	Age	Previous treatment	Liver cirrhosis	Lesion number	Lesion size (cm³)	Lesion SUVmax
1	M	59	Surgery, TACE, ICI	+	2	106.61	9.61
						3.95	9.47
2	M	64	RFA, ICI	+	1	1.78	4.69
3	M	67	Liver transplantation, radiotherapy, ICI	–	1	0.47	4.53
4	M	73	Surgery, TACE, RFA, ICI	–	1	213.25	9.42
5	M	46	Surgery, TACE, ICI	+	3	2.9	20.05
						1.63	20.96
						0.89	15.65
6	M	61	Surgery, TACE, RFA, ICI	+	1	4.4	7.39
7	M	71	Surgery, TACE, RFA, ICI	+	1	3.37	5.82
8	M	50	TACE, ICI	+	2	1.46	4.38
						2.30	3.31
9	M	38	TACE, radiotherapy, ICI	+	1	18.14	8.15
Mean ± SD		58.78 ± 11.85				27.78 ± 62.72	9.49 ± 5.87

TACE, transcatheter arterial chemoembolization; RFA, Radio Frequency Ablation; ICI, immune checkpoint inhibitor

ISSN: 1471-2342